160 related articles for article (PubMed ID: 37204480)
1. Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer.
Zhou H; Yang L; Lin X; Chan TF; Lee NP; Tse WKF; Zhang X; Li R; Lai KP
Aging (Albany NY); 2023 May; 15(10):4304-4318. PubMed ID: 37204480
[TBL] [Abstract][Full Text] [Related]
2. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression.
Chen S; Zhou B; Huang W; Li Q; Yu Y; Kuang X; Huang H; Wang W; Xie P
Cell Death Dis; 2023 Dec; 14(12):830. PubMed ID: 38097536
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J
BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Ubiquitin-Specific Protease15 (USP15) Promotes Tumor Growth and Inhibits Apoptosis and Correlated With Poor Disease-Free Survival in Hepatocellular Carcinoma.
Yao XQ; Li L; Piao LZ; Zhang GJ; Huang XZ; Wang Y; Liang ZL
Technol Cancer Res Treat; 2020; 19():1533033820967455. PubMed ID: 33267707
[TBL] [Abstract][Full Text] [Related]
5. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
6. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.
Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG
Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342
[TBL] [Abstract][Full Text] [Related]
7. High ubiquitin-specific protease 44 expression induces DNA aneuploidy and provides independent prognostic information in gastric cancer.
Nishimura S; Oki E; Ando K; Iimori M; Nakaji Y; Nakashima Y; Saeki H; Oda Y; Maehara Y
Cancer Med; 2017 Jun; 6(6):1453-1464. PubMed ID: 28544703
[TBL] [Abstract][Full Text] [Related]
8.
Chen X; Wu X; Lei W
Future Oncol; 2021 Jan; 17(3):279-289. PubMed ID: 32956592
[No Abstract] [Full Text] [Related]
9. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 44 inhibits cell growth by suppressing AKT signaling in non-small cell lung cancer.
Zhang YK; Tian WZ; Zhang RS; Zhang YJ; Ma HT
Kaohsiung J Med Sci; 2019 Sep; 35(9):535-541. PubMed ID: 31197957
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
13. USP14 activation promotes tumor progression in hepatocellular carcinoma.
Huang G; Li L; Zhou W
Oncol Rep; 2015 Dec; 34(6):2917-24. PubMed ID: 26397990
[TBL] [Abstract][Full Text] [Related]
14. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma.
Chen Y; Zhao Y; Yang X; Ren X; Huang S; Gong S; Tan X; Li J; He S; Li Y; Hong X; Li Q; Ding C; Fang X; Ma J; Liu N
Nat Commun; 2022 Jan; 13(1):501. PubMed ID: 35079021
[TBL] [Abstract][Full Text] [Related]
15. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.
Liu T; Sun B; Zhao X; Li Y; Zhao X; Liu Y; Yao Z; Gu Q; Dong X; Shao B; Lin X; Liu F; An J
Mol Cancer Ther; 2015 Sep; 14(9):2121-31. PubMed ID: 26232424
[TBL] [Abstract][Full Text] [Related]
16. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death.
Zahid KR; Han S; Zhou F; Raza U
Cell Oncol (Dordr); 2019 Feb; 42(1):55-66. PubMed ID: 30238408
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor role of miR-4782-3p in hepatocellular carcinoma.
Bo W; Hu Y; Feng X; Zhang H; Tian L; Liu A
Oncol Rep; 2016 Apr; 35(4):2107-12. PubMed ID: 26782643
[TBL] [Abstract][Full Text] [Related]
19. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
